Genpact Limited (NYSE:G – Get Free Report) was the recipient of a significant decrease in short interest in the month of February. As of February 15th, there was short interest totalling 4,570,000 shares, a decrease of 15.5% from the January 31st total of 5,410,000 shares. Based on an average daily trading volume, of 1,570,000 shares, the short-interest ratio is presently 2.9 days. Currently, 2.8% of the shares of the company are short sold.
Insider Buying and Selling at Genpact
In other news, CEO Balkrishan Kalra sold 13,600 shares of the firm’s stock in a transaction dated Friday, December 13th. The shares were sold at an average price of $44.60, for a total transaction of $606,560.00. Following the completion of the sale, the chief executive officer now owns 267,404 shares in the company, valued at approximately $11,926,218.40. This trade represents a 4.84 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Piyush Mehta sold 12,000 shares of the company’s stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the completion of the transaction, the senior vice president now owns 151,182 shares in the company, valued at approximately $6,475,125.06. This trade represents a 7.35 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 2.80% of the company’s stock.
Hedge Funds Weigh In On Genpact
A number of institutional investors have recently added to or reduced their stakes in the stock. Jensen Investment Management Inc. boosted its stake in shares of Genpact by 6.4% during the third quarter. Jensen Investment Management Inc. now owns 189,985 shares of the business services provider’s stock valued at $7,449,000 after purchasing an additional 11,410 shares in the last quarter. Stifel Financial Corp acquired a new stake in Genpact during the 3rd quarter worth approximately $1,197,000. Blue Trust Inc. grew its holdings in Genpact by 8.7% during the 4th quarter. Blue Trust Inc. now owns 5,531 shares of the business services provider’s stock worth $217,000 after acquiring an additional 441 shares during the last quarter. Burney Co. increased its position in Genpact by 242.8% in the 4th quarter. Burney Co. now owns 130,798 shares of the business services provider’s stock valued at $5,618,000 after acquiring an additional 92,641 shares during the period. Finally, KBC Group NV bought a new position in shares of Genpact during the fourth quarter valued at $298,000. 96.03% of the stock is currently owned by institutional investors and hedge funds.
Genpact Price Performance
Genpact (NYSE:G – Get Free Report) last issued its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing analysts’ consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. Sell-side analysts forecast that Genpact will post 3.21 EPS for the current fiscal year.
Genpact Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th will be paid a $0.17 dividend. This is an increase from Genpact’s previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.32%. The ex-dividend date of this dividend is Tuesday, March 11th. Genpact’s dividend payout ratio (DPR) is presently 23.94%.
Analyst Upgrades and Downgrades
Several analysts recently weighed in on the company. Robert W. Baird lifted their price target on Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a report on Friday, November 8th. Jefferies Financial Group raised Genpact from a “hold” rating to a “buy” rating and lifted their target price for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Mizuho boosted their target price on shares of Genpact from $45.00 to $55.00 and gave the company a “neutral” rating in a research report on Monday, February 10th. TD Cowen raised shares of Genpact from a “hold” rating to a “buy” rating and raised their price target for the stock from $45.00 to $60.00 in a research report on Friday, February 7th. Finally, Needham & Company LLC lifted their price objective on shares of Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a research note on Friday, February 7th. Six investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, Genpact currently has a consensus rating of “Hold” and a consensus price target of $48.44.
View Our Latest Report on Genpact
Genpact Company Profile
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also
- Five stocks we like better than Genpact
- Expert Stock Trading Psychology Tips
- Is Myers Industries Poised for a Breakout?
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Is BigBear.ai’s 25% Plunge a False Alarm or Fire Sale?
- The How And Why of Investing in Oil Stocks
- Broadcom Confirmed Its AI Outlook: Stock to Hit New Highs Soon
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.